USOR 21501_WCT (Veru Inc.) | Maryland Oncology Hematology USOR 21501_WCT (Veru Inc.) – Maryland Oncology Hematology

USOR 21501_WCT (Veru Inc.)

Trial Information

A Phase 3 Study to Evaluate the Efficacy and Safety of Enobosarm in Combination with Abemaciclib (Enobosarm Combination Group) Compared to Estrogen Blocking Agent (Control Treatment Group) for the Second Line Treatment of ER+HER2- Metastatic Breast Cancer in Patients Who have Shown Previous Disease Progression on an Estrogen Blocking Agent Plus Palbociclib



Sponsor: Worldwide Clinical Trials

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Breast Cancer

Investigator

Werner, Jeanine

Sponsor

Worldwide Clinical Trials
« Clinical Trails Main

Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology